Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

Recent Press Coverage

  1. COVID-19 spurred an increase in gifted medical devices, but the donations have left some facilities in under-resourced countries overwhelmed. PATH experts explain how too many facilities often lack training to use the equipment or funding to maintain it.
    Published: February 2024
  2. The World Health Organization granted prequalification to the novel oral polio vaccine type 2 (nOPV2), an innovative vaccine developed by a consortium of experts including PATH.
    Published: January 2024
  3. PATH has again been named to Forbes’ annual list of the largest charities in the United States, based solely on private contributions. PATH scored 99 percent in fundraising efficiency and 89 percent in charitable commitment.
    Published: December 2023
  4. PATH President and CEO Nikolaj Gilbert outlines the four global health paradigm shifts that are needed to achieve universal health coverage.
    Published: November 2023

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

946 Item s
946 Item s
    Date
    From
    To
  1. The CEPI-backed Research Preparedness Program in East and Central Africa aims to bolster regional clinical trial capacity and disease outbreak readiness.
    Published: March 2025
    Press Release
  2. Published: March 2025
    Announcement
  3. Results from a Phase 3 clinical study of Innovax’s WHO prequalified vaccine can help expand access globally and give countries another option for affordable, sustainable HPV vaccine.
    Published: March 2025
    Announcement
  4. The milestone marks the first-ever prequalification of an RSV vaccine and paves the way for improving respiratory disease prevention for infants around the world.
    Published: March 2025
    Statement
  5. The new Center enhances collaboration between PATH's technical and advocacy experts, boosting our ability to expand access to lifesaving health care through policy.
    Published: March 2025
    Press Release